Skeletal Dysplasia Account Manager - Upstate NY/Northern NE

Role: Skeletal Dysplasia Account Manager responsible for launching Infigratinib for achondroplasia, focusing on community engagement and sales growth. Responsibilities: develop and execute territory business plans targeting geneticists, pediatric endocrinologists, orthopedic specialists, and multidisciplinary clinics; demonstrate clinical expertise in achondroplasia and the broader skeletal dysplasia landscape; build relationships with healthcare professionals and advocacy groups; collaborate with cross-functional teams to maximize product adoption and customer satisfaction; ensure compliance with regulations and company policies. Requirements: 8–10 years in pharma or biotech, with 4+ years in rare or pediatric genetic diseases; BS/BA required, MBA preferred; proven success in product launches and account management; strong communication, strategic thinking, and influence skills; willingness to travel extensively. HighValue: rare pediatric disease, skeletal dysplasia, achondroplasia, product launch experience, stakeholder engagement, community focus, deep clinical understanding, and AI fluency. WorkSetup: Northeast region covering Boston, Washington DC, Pittsburgh, New England, New York, and New Jersey, with a hybrid work model and extensive travel expectations.